Breaking News Instant updates and real-time market news.

AN

AutoNation

$49.71

-0.05 (-0.10%)

, TSL

Trina Solar

$10.37

0.105 (1.02%)

10:31
10/06/16
10/06
10:31
10/06/16
10:31

On The Fly: Top five analyst upgrades

Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. AutoNation (AN) upgraded to Neutral from Sell at Goldman with analyst David Tamberrino saying valuation has bottomed and could be flat to slightly up in the near-term as SAAR bounces around the low-to-mid 17M range. 2. Trina Solar (TSL), Yingli Green Energy (YGE), and JA Solar (JASO) were upgraded to Buy from Sell at Axiom while the firm upgraded SolarCity (SCTY) to Hold from Sell. 3. PNC Financial (PNC) upgraded to Market Perform from Underperform at Raymond James with analyst David Long saying negative earnings revisions over the past two years have likely hit an inflection point. 4. Big 5 Sporting (BGFV) upgraded to Buy from Hold at Deutsche Bank with analyst Mike Baker citing accelerating sales trends and higher earnings power from profitability improvements. 5. Booz Allen (BAH) upgraded to Outperform from Market Perform at Raymond James with analyst Brian Gesuale saying the recent selloff creates an attractive entry point. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.

AN

AutoNation

$49.71

-0.05 (-0.10%)

TSL

Trina Solar

$10.37

0.105 (1.02%)

YGE

Yingli Green Energy

$4.01

0.12 (3.08%)

JASO

JA Solar

$6.59

0.65 (10.94%)

SCTY

SolarCity

$20.05

0.26 (1.31%)

PNC

PNC Financial

$91.38

-0.14 (-0.15%)

BGFV

Big 5 Sporting

$13.87

-0.03 (-0.22%)

BAH

Booz Allen

$31.00

0.69 (2.28%)

  • 14

    Oct

  • 28

    Oct

  • 31

    Oct

  • 02

    Nov

  • 17

    Nov

  • 13

    Jan

AN AutoNation
$49.71

-0.05 (-0.10%)

09/07/16
KING
09/07/16
INITIATION
Target $57
KING
Buy
AutoNation initiated with a Buy at CL King
CL King analyst William Armstrong initiated AutoNation with a Buy rating and $57 price target.
09/08/16
09/08/16
INITIATION

On The Fly: Top analyst initiations
Catch up on today's top analyst initiations with this list compiled by The Fly: 1. Tesla (TSLA) initiated with an Underperform, $160 target at Cowen with analyst Jeffrey Osborne saying the company is well positioned for the long term but has a "material amount of execution risk" over the next 12 to 18 months. 2. AutoNation (AN) initiated with a Buy at CL King. 3. Wingstop (WING) initiated with an Overweight at KeyBanc. 4. Vivint Solar (VSLR), Sunrun (RUN), and SolarEdge (SEDG) initiated with an Outperform at JMP Securities with the firm initiated First Solar (FSLR) and SunPower (SPWR) with an Underperform. The firm also initiated Canadian Solar (CSIQ) with a Market Perform. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
10/06/16
GSCO
10/06/16
UPGRADE
GSCO
Neutral
AutoNation upgraded to Neutral from Sell at Goldman
Goldman analyst David Tamberrino upgraded AutoNation to Neutral and lowered its price target to $49 from $52 saying valuation has bottomed and and could be flat to slightly up in the near-term as SAAR bounces around the low-to-mid 17M range.
10/06/16
GSCO
10/06/16
NO CHANGE
GSCO
Autos and Autos Parts sector downgraded to Cautious from Neutral at Goldman
Goldman analyst David Tamberrino downgraded the Autos and Auto Parts sector to Cautious from Neutral saying the US Auto cycle peaked in 2015 and is being held up by increasing OEM incentives. The analyst said OEM earnings will decline in 2017/2018 as negative pricing and lower production pressure North American results, but expects suppliers' earnings to hold up longer. The analyst sees upside to Delphi (DLPH) and Harman (HAR) given exposure to secular growth areas and upside to Goodyear Tire (GT) given secular HVA tire growth. Tamberrino downgraded Lear (LEA) to Sell citing elevated expectations and valuation, cut BorgWarner (BWA) to Neutral on valuation, downgraded Tesla (TSLA) to Neutral on execution risk and capital deployment, and upgraded AutoNation (AN) to Neutral given a more defensive business.
TSL Trina Solar
$10.37

0.105 (1.02%)

09/30/16
ROTH
09/30/16
NO CHANGE
ROTH
Possible Chinese tariff cuts a negative for solar names, says Roth Capital
Roth Capital analyst Philip Shen noted media reports in China indicating that certain solar feed-in tariff levels may be cut by 23-52%, depending on region and project type, in January 2017. While there appears to be some confusion on which projects may qualify for the 2016 tariff ahead of the 2017 FIT stepdown, Shen tells investors that he sees the reports on the whole as more negative news for the industry. Publicly traded companies in the solar space include Canadian Solar (CSIQ), First Solar (FSLR), JA Solar (JASO), SolarCity (SCTY), SunEdison (SUNEQ), SunPower (SPWR), Trina Solar (TSL) and Yingli Green Energy (YGE).
07/15/16
COWN
07/15/16
DOWNGRADE
Target $7.5
COWN
Market Perform
Trina Solar downgraded to Market Perform from Outperform at Cowen
Cowen analyst Jeffrey Osborne downgraded Trina Solar to Market Perform and lowered its price target to $7.50 from $11. The analyst said checks indicate US module pricing has dropped more than expected, by 5-10 cents/watt for Q4 delivery due to the fall off of demand in China and new capacity coming online outside of China. Osborne recommends staying away from module only or module only/China project firms in the near term as estimates get reset and note the problems could get worse before they get better.
10/06/16
AXIO
10/06/16
NO CHANGE
AXIO
Axiom upgrades solar sector sector to Overweight from Underweight
As previously reported, Axiom analyst Gordon L. Johnson II upgraded several stocks in the solar sector, including raising his ratings on Yingli Green Energy (YGE) to Buy from Sell, Trina Solar (TSL) to Buy from Sell, JA Solar (JASO) to Buy from Sell and SolarCity (SCTY) to Hold from Sell. The firm has also upgraded its solar sector rating to Market Overweight from Market Underweight, as they believe China's proposed Jul. 1, 2017 tariff cut will usher in about 25GW of 1H17 Chinese "pull-in" demand and that a possible election win by Hillary Clinton would serve as sentiment tailwind pushing clean energy funds to "refocus" on solar stocks.
10/06/16
AXIO
10/06/16
UPGRADE
AXIO
Buy
Trina Solar upgraded to Buy from Sell at Axiom
YGE Yingli Green Energy
$4.01

0.12 (3.08%)

07/08/16
OTRG
07/08/16
NO CHANGE
OTRG
Solar PV Manufactures downgraded to Negative from Mixed at OTR Global
OTR Global's changed its view on the Solar PV Manufactures sector to Negative from Mixed. The firm's checks indicate the outlook for 2016 solar PV installations has weakened due to slowing Q2 demand with April pricing falling below expectations in all regions, including China.
10/06/16
AXIO
10/06/16
UPGRADE
AXIO
Buy
Yingli Green Energy upgraded to Buy from Sell at Axiom
JASO JA Solar
$6.59

0.65 (10.94%)

10/06/16
AXIO
10/06/16
UPGRADE
AXIO
Buy
JA Solar upgraded to Buy from Sell at Axiom
SCTY SolarCity
$20.05

0.26 (1.31%)

10/03/16
OPCO
10/03/16
NO CHANGE
OPCO
Perform
Review process of SolarCity acquisition may be delayed, says Oppenheimer
Oppenheimer analyst Colin Rusch believes the SEC review process of Tesla's (TSLA) acquisition of SolarCity (SCTY) could be delayed due to recent activity, especially new litigation. Further, the analyst believes extension to the timeline is likely to work against the deal given the risk of ongoing "collaboration to trigger gun-jumping rules." Rusch reiterates a Perform rating on Tesla's shares.
10/06/16
AXIO
10/06/16
UPGRADE
AXIO
Hold
SolarCity upgraded to Hold from Sell at Axiom
PNC PNC Financial
$91.38

-0.14 (-0.15%)

09/19/16
BMOC
09/19/16
UPGRADE
BMOC
Outperform
PNC Financial upgraded on imrpoved outlook at BMO Capital
As noted earlier, BMO Capital upgraded PNC to Outperform from Market Perform. Analyst Lana Chan says she thinks that the company's results can beat expectations going forward, driven by fee income, tight expense management, and acceleration in loan growth over the next few years. She says that the stock's valuation is "compelling." Target to $101 from $94.
09/19/16
BMOC
09/19/16
UPGRADE
BMOC
Outperform
PNC Financial upgraded to Outperform from Market Perform at BMO Capital
09/07/16
BOFA
09/07/16
NO CHANGE
Target $100
BOFA
Buy
PNC Financial estimates raised above consensus, target to $100 at BofA/Merrill
BofA/Merrill analysts led by Erika Najarian raised PNC Financial estimates above consensus and increased its price target to $100 from $90. The analyst believes incremental cost savings could lead to higher consensus estimates and expects management to provide more detail into 2017 earnings at a competitor conference today. Najarian prefers PNC given it can execute on earnings growth without the help of the macro environment and reiterates his Buy rating on shares.
10/06/16
RAJA
10/06/16
UPGRADE
RAJA
Market Perform
PNC Financial upgraded to Market Perform from Underperform at Raymond James
Raymond James analyst David Long upgraded PNC Financial ahead of the Q3 report saying negative earnings revisions over the past two years have likely hit an inflection point.
BGFV Big 5 Sporting
$13.87

-0.03 (-0.22%)

02/08/16
STFL
02/08/16
UPGRADE
STFL
Buy
Big 5 Sporting upgraded to Buy from Hold at Stifel
10/06/16
DBAB
10/06/16
UPGRADE
Target $16.5
DBAB
Buy
Big 5 Sporting upgraded to Buy from Hold at Deutsche Bank
Deutsche Bank analyst Mike Baker upgraded Big 5 Sporting Goods to Buy citing accelerating sales trends and higher earnings power from profitability improvements. The analyst believes the shares are not fully reflecting these positives and he upped his price target for the name to $16.50 from $10.
02/08/16
02/08/16
UPGRADE

On The Fly: Analyst Upgrade Summary
Today's noteworthy upgrades include: Amedisys (AMED) upgraded to Outperform from Perform at Oppenheimer... American Campus (ACC) upgraded to Buy at Canaccord... Beacon Roofing (BECN) upgraded to Strong Buy from Outperform at Raymond James... Big 5 Sporting (BGFV) upgraded on potential Sports Authority closures at Stifel... CenterState Banks (CSFL) upgraded to Outperform from Market Perform at Fig Partners... Cisco (CSCO) upgraded to Neutral from Underperform at Macquarie... Dollar Tree (DLTR) upgraded to Outperform from Market Perform at Telsey Advisory... Dow Chemical (DOW) upgraded to Positive from Neutral at Susquehanna... Essex Property Trust (ESS) upgraded to Buy from Neutral at Mizuho... Globant (GLOB) upgraded to Buy from Neutral at Citi... Kinross Gold (KGC) upgraded on valuation, higher gold price at BMO Capital... L Brands (LB) upgraded to Buy from Hold at Brean Capital... Marvell (MRVL) upgraded to Buy from Sell at B. Riley... Munich Re (MURGY) upgraded to Neutral from Underperform at Credit Suisse... OM Asset Management (OMAM) upgraded to Buy from Neutral at Citi... Orbital ATK (OA) upgraded to Overweight from Sector Weight at KeyBanc... SCANA (SCG) upgraded to Buy from Neutral at Mizuho... Sensient (SXT) upgraded to Buy from Hold at Gabelli... St. Jude Medical (STJ) upgraded to Hold from Sell at Canaccord... Suffolk Bancorp (SCNB) upgraded to Outperform from Market Perform at Fig Partners... Supernus (SUPN) upgraded to Buy from Hold at Jefferies... Ultimate Software (ULTI) upgraded to Outperform from Market Perform at FBR Capital... ZAGG (ZAGG) upgraded to Outperform from Market Perform at Northland... athenahealth (ATHN) upgraded to Buy from Hold at Topeka.
02/08/16
STFL
02/08/16
UPGRADE
STFL
Buy
Big 5 Sporting upgraded on potential Sports Authority closures at Stifel
As noted earlier, Stifel upgraded Big 5 to Buy from Hold. The firm estimates that the potential closure of The Sports Authority's stores can boost Big Five's EPS by about 15%. .Stifel also thinks Big 5 could benefit from the relocation of the St. Louis Rams to LA, and from positive firearm trends. Target $14.50.
BAH Booz Allen
$31.00

0.69 (2.28%)

10/06/16
RAJA
10/06/16
UPGRADE
Target $36
RAJA
Outperform
Booz Allen upgraded to Outperform from Market Perform at Raymond James
Raymond James analyst Brian Gesuale upgraded Booz Allen to Outperform and established a $36 price target saying yesterday's selloff creates an attractive entry point. The analyst said they do not expect an adverse impact to Booz Allen's NSA footprint following the latest employee controversy and notes it is only 5% of total revenue. Further, Gesuale said fundamentals are accelerating and earnings revision risk is to the upside.
10/05/16
COWN
10/05/16
NO CHANGE
COWN
Outperform
Impact on Booz Allen from employee arrest unclear, says Cowen
Cowen analyst Cai von Rumohr said it is still unclear what impact the recent arrest of a Booz Allen employee alleged to have stolen classified computer codes while contracted at the NSA may have on the company. Since this incident is the second of its sort involving a Booz Allen employee, after Edward Snowden, it could have an impact on the company's brand image, the analyst said. However, von Rumohr noted that Booz Allen did not face any litigation, lose any contracts, or have any direct impact on its revenues in the wake of the Snowden incident and that its shares bounced back relatively quickly after the fall associated with that event. The firm keeps an Outperform rating on Booz Allen shares.
04/12/16
04/12/16
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. AstraZeneca (AZN) downgraded to Sell at Goldman saying the risk/reward is negative due to valuation and high pipeline expectations. 2. Avon Products (AVP) downgraded to Neutral at Piper Jaffray by analyst Stephanie Wissink, who said Avon's topline growth now relies almost exclusively on international markets, where economic uncertainty persists. 3. Booz Allen (BAH) downgraded to Market Perform at Raymond James with analyst Brian Gesuale saying near-term consensus expectations are overly optimistic in terms of growth, despite management cautioning about needing time to staff recent contract wins and incremental investments required to drive long-term growth. 4. Hertz (HTZ) downgraded to Neutral at Credit Suisse by analyst Anjaneya Singh, who cited lower confidence in the company's outlook following yesterday's Q1 preannouncement. He adds that Hertz indicated that weaker pricing would cause revenue per available car day to decline 2.5%-3.5%. 5. L Brands (LB) downgraded to Neutral at Goldman with analyst Lindsay Drucker Mann saying last week's restructuring announcement will pressure Victoria's Secret near-term comp sales growth, which may result in multiple compression until visibility to comp re-acceleration improves. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
04/12/16
RAJA
04/12/16
DOWNGRADE
RAJA
Market Perform
Booz Allen downgraded to Market Perform from Outperform at Raymond James
Raymond James analyst Brian Gesuale downgraded Booz Allen to Market Perform saying near-term consensus expectations are overly optimistic in terms of growth, despite management cautioning about needing time to staff recent contract wins and incremental investments required to drive long-term growth. The analyst believes near-term share appreciation may be capped near-term with shares trading at a healthy premium to peers.

TODAY'S FREE FLY STORIES

BMRN

BioMarin

$82.21

-1.12 (-1.34%)

, ESALY

Eisai

$57.91

0.59 (1.03%)

04:55
12/04/16
12/04
04:55
12/04/16
04:55
Conference/Events
American Epilepsy Society to hold annual meeting »

70th Annual Meeting of…

BMRN

BioMarin

$82.21

-1.12 (-1.34%)

ESALY

Eisai

$57.91

0.59 (1.03%)

GWPH

GW Pharmaceuticals

$112.32

3.04 (2.78%)

IART

Integra LifeSciences

$75.78

-1.07 (-1.39%)

MDT

Medtronic

$72.01

0.13 (0.18%)

MNK

Mallinckrodt

$53.61

0.51 (0.96%)

NVTA

Invitae

$6.95

0.16 (2.36%)

SAGE

SAGE Therapeutics

$49.02

-0.23 (-0.47%)

WTKWY

Wolters Kluwer

$34.08

-0.39 (-1.13%)

ZGNX

Zogenix

$13.05

0.35 (2.76%)

ZYNE

Zynerba

$13.64

0.83 (6.48%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Dec

  • 06

    Dec

  • 07

    Dec

  • 12

    Dec

  • 14

    Dec

  • 28

    Jan

  • 27

    Apr

CELG

Celgene

$117.63

-1.24 (-1.04%)

04:55
12/04/16
12/04
04:55
12/04/16
04:55
Conference/Events
Celgene to hold an analyst and investor event »

Management holds an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    Dec

  • 06

    Dec

INCY

Incyte

$102.02

2.09 (2.09%)

, PFE

Pfizer

$31.63

0.17 (0.54%)

04:55
12/04/16
12/04
04:55
12/04/16
04:55
Conference/Events
Canaccord biotech analyst to hold a dinner meeting »

In conjunction with the…

INCY

Incyte

$102.02

2.09 (2.09%)

PFE

Pfizer

$31.63

0.17 (0.54%)

LLY

Eli Lilly

$67.71

1.74 (2.64%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    Dec

  • 06

    Dec

  • 15

    Dec

JUNO

Juno Therapeutics

$20.43

0.53 (2.66%)

, KITE

Kite Pharma

$50.76

0.04 (0.08%)

21:25
12/03/16
12/03
21:25
12/03/16
21:25
Conference/Events
Canaccord biotech analyst to hold a dinner meeting »

In conjunction with the…

JUNO

Juno Therapeutics

$20.43

0.53 (2.66%)

KITE

Kite Pharma

$50.76

0.04 (0.08%)

BLUE

bluebird bio

$69.75

1.1 (1.60%)

NVS

Novartis

$68.17

0.42 (0.62%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Dec

  • 03

    Dec

  • 06

    Dec

09:15
12/03/16
12/03
09:15
12/03/16
09:15
General news
Breaking General news story  »

New York Federal Reserve…

09:15
12/03/16
12/03
09:15
12/03/16
09:15
General news
Breaking General news story  »

New York Federal Reserve…

04:55
12/03/16
12/03
04:55
12/03/16
04:55
General news
Breaking General news story  »

New York Federal Reserve…

04:55
12/03/16
12/03
04:55
12/03/16
04:55
General news
Breaking General news story  »

New York Federal Reserve…

BMRN

BioMarin

$82.21

-1.12 (-1.34%)

, ESALY

Eisai

$57.91

0.59 (1.03%)

04:55
12/03/16
12/03
04:55
12/03/16
04:55
Conference/Events
American Epilepsy Society to hold annual meeting »

70th Annual Meeting of…

BMRN

BioMarin

$82.21

-1.12 (-1.34%)

ESALY

Eisai

$57.91

0.59 (1.03%)

GWPH

GW Pharmaceuticals

$112.32

3.04 (2.78%)

IART

Integra LifeSciences

$75.78

-1.07 (-1.39%)

MDT

Medtronic

$72.01

0.13 (0.18%)

MNK

Mallinckrodt

$53.61

0.51 (0.96%)

NVTA

Invitae

$6.95

0.16 (2.36%)

SAGE

SAGE Therapeutics

$49.02

-0.23 (-0.47%)

WTKWY

Wolters Kluwer

$34.08

-0.39 (-1.13%)

ZGNX

Zogenix

$13.05

0.35 (2.76%)

ZYNE

Zynerba

$13.64

0.83 (6.48%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Dec

  • 05

    Dec

  • 06

    Dec

  • 07

    Dec

  • 12

    Dec

  • 14

    Dec

  • 28

    Jan

  • 27

    Apr

WMT

Wal-Mart

$70.88

0.21 (0.30%)

18:17
12/02/16
12/02
18:17
12/02/16
18:17
Periodicals
Wal-Mart to pay $7.5M to settle same-sex spouse benefit case, Reuters reports »

Wal-Mart said it would…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GMED

Globus Medical

$21.89

0.12 (0.55%)

, TLN

Talen Energy

18:14
12/02/16
12/02
18:14
12/02/16
18:14
Hot Stocks
S&P announces changes to S&P MidCap 400, S&P SmallCap 600 indices »

S&P Dow Jones Indices…

GMED

Globus Medical

$21.89

0.12 (0.55%)

TLN

Talen Energy

UMBF

UMB Financial

$77.00

-0.43 (-0.56%)

IM

Ingram Micro

$38.88

1.31 (3.49%)

HMST

HomeStreet

$29.35

-0.2 (-0.68%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

JNJ

Johnson & Johnson

$111.96

0.58 (0.52%)

, ALIOF

Actelion

$206.01

15.21 (7.97%)

18:11
12/02/16
12/02
18:11
12/02/16
18:11
Periodicals
Johnson & Johnson said to raise offer for Actelion above $250, Bloomberg says »

Johnson &…

JNJ

Johnson & Johnson

$111.96

0.58 (0.52%)

ALIOF

Actelion

$206.01

15.21 (7.97%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CE

Celanese

$79.10

0.3 (0.38%)

18:00
12/02/16
12/02
18:00
12/02/16
18:00
Hot Stocks
Celanese to raise list, off-list selling prices for paraformaldehyde »

Celanese Corporation…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HMST

HomeStreet

$29.35

-0.2 (-0.68%)

, GMED

Globus Medical

$21.89

0.12 (0.55%)

17:56
12/02/16
12/02
17:56
12/02/16
17:56
Hot Stocks
On The Fly: After Hours Movers »

HIGHER: HomeStreet…

HMST

HomeStreet

$29.35

-0.2 (-0.68%)

GMED

Globus Medical

$21.89

0.12 (0.55%)

BGS

B&G Foods

$42.50

0.2 (0.47%)

ZEN

Zendesk

$21.17

0.34 (1.63%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    Dec

  • 09

    Jan

ZEN

Zendesk

$21.17

0.34 (1.63%)

17:53
12/02/16
12/02
17:53
12/02/16
17:53
Hot Stocks
Zendesk says SVPs Amanda Kleha and Marcus Bragg to resign »

On November 29, Amanda…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    Dec

AIXG

Aixtron

$3.97

-0.05 (-1.24%)

17:42
12/02/16
12/02
17:42
12/02/16
17:42
Periodicals
President Obama blocks China's Fujian from acquiring Aixtron, CNBC reports »

President Barack Obama…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CX

CEMEX

$7.83

0.09 (1.16%)

17:31
12/02/16
12/02
17:31
12/02/16
17:31
Hot Stocks
CEMEX to divest ready-mix concrete pumping assets in Mexico »

CEMEX announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SRNE

Sorrento Therapeutics

$5.15

-0.1 (-1.90%)

17:30
12/02/16
12/02
17:30
12/02/16
17:30
Syndicate
Breaking Syndicate news story on Sorrento Therapeutics »

Sorrento files to sell…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Dec

MBRX

Moleculin Biotech

$2.63

-0.14 (-5.05%)

17:29
12/02/16
12/02
17:29
12/02/16
17:29
Syndicate
Breaking Syndicate news story on Moleculin Biotech »

Moleculin Biotech files…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Dec

NEOG

Neogen

$61.59

-1.46 (-2.32%)

17:28
12/02/16
12/02
17:28
12/02/16
17:28
Hot Stocks
Neogen acquires U.K.-based Quat-Chem, terms undisclosed »

Neogen announced that it…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RRC

Range Resources

$36.36

-0.23 (-0.63%)

17:25
12/02/16
12/02
17:25
12/02/16
17:25
Hot Stocks
Breaking Hot Stocks news story on Range Resources »

SailingStone Capital…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EOG

EOG Resources

$103.74

-1.01 (-0.96%)

17:25
12/02/16
12/02
17:25
12/02/16
17:25
Syndicate
Breaking Syndicate news story on EOG Resources »

EOG Resources files to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Dec

HMST

HomeStreet

$29.35

-0.2 (-0.68%)

, UMBF

UMB Financial

$77.00

-0.43 (-0.56%)

17:22
12/02/16
12/02
17:22
12/02/16
17:22
Hot Stocks
Breaking Hot Stocks news story on HomeStreet, UMB Financial »

HomeStreet to replace UMB…

HMST

HomeStreet

$29.35

-0.2 (-0.68%)

UMBF

UMB Financial

$77.00

-0.43 (-0.56%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

UMBF

UMB Financial

$77.00

-0.43 (-0.56%)

, IM

Ingram Micro

$38.88

1.31 (3.49%)

17:21
12/02/16
12/02
17:21
12/02/16
17:21
Hot Stocks
UMB Financial to replace Ingram Micro in S&P 400 as of 12/6 close »

Tianjin Tianhai…

UMBF

UMB Financial

$77.00

-0.43 (-0.56%)

IM

Ingram Micro

$38.88

1.31 (3.49%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GMED

Globus Medical

$21.89

0.12 (0.55%)

, TLN

Talen Energy

17:20
12/02/16
12/02
17:20
12/02/16
17:20
Hot Stocks
Globus Medical to replace Talen Energy in S&P 400 as of 12/6 close »

Riverstone Holdings is…

GMED

Globus Medical

$21.89

0.12 (0.55%)

TLN

Talen Energy

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.